1 Center for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ, UK.
2 Department of Medical Oncology, Barts Health NHS Trust, St Bartholomew's Hospital, West Smithfield, London, EC1A 7BE, UK.
3 Center for Tumor Microenvironment, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ, UK.
4 Centre for Haemato-Oncology, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ, UK.
5 Medicines and Healthcare Products Regulatory Agency (MHRA), London, UK.
6 Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.
7 Polaris Pharmaceuticals, Inc., San Diego, CA, 92121, USA.
8 Department of Histopathology, Barts Health NHS Trust, Royal London Hospital, London, E1 1BB, UK.
9 Center for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute (BCI)-a Cancer Research UK Center of Excellence, Queen Mary University of London, John Vane Science Center, London, EC1M 6BQ, UK. p.w.szlosarek@qmul.ac.uk.
10 Department of Medical Oncology, Barts Health NHS Trust, St Bartholomew's Hospital, West Smithfield, London, EC1A 7BE, UK. p.w.szlosarek@qmul.ac.uk.